Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Delirium
RCT	42 people with advanced terminal cancer, all receiving haloperidol, metoclopramide, or both	Delirium (measured by Mini-Mental State scores) 24–48 hours with hypodermoclysis with baseline Absolute results reported graphically	No direct comparison between groups Reported as no significant change in scores from baseline with hypodermoclysis P value not reported